[Featured Stock] Jinwon Life Sciences Rises 15% on Subsidiary's Selection by US Rapid Response Cooperation Organization
Jinwon Life Sciences is rising more than 15% on news that its subsidiary VGXI has been selected as a member of the Rapid Response Partnership Vehicle (RRPV), supported by the U.S. government.
![[Featured Stock] Jinwon Life Sciences Rises 15% on Subsidiary's Selection by US Rapid Response Cooperation Organization](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
As of 10:18 AM on the 31st, Jinwon Life Sciences is trading at 3,150 KRW, up 15.38% (420 KRW) from the previous trading day.
On this day, Jinwon Life Sciences announced that its subsidiary VGXI, a contract development and manufacturing organization (CDMO) specializing in nucleic acid biopharmaceuticals such as gene therapies, DNA vaccines, and RNA drugs, has been selected as a member of the Rapid Response Partnership Vehicle (RRPV), supported by the Biomedical Advanced Research and Development Authority (BARDA) under the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [Tomorrow's Weather] Rain Across the Country Brings Relief from Heat...Caution Advised for Strong Winds
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Park Young-geun, CEO of Jinwon Life Sciences, stated, "We are honored to be selected as a member of the Rapid Response Partnership Vehicle (RRPV)." He emphasized, "Based on our achievements in producing vaccines necessary for infectious diseases such as influenza, Ebola, MERS, and COVID-19, we have gained the opportunity to participate in future pandemic responses together with the members of the Rapid Response Partnership Vehicle (RRPV)."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
